ID
27673
Description
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977
Keywords
Versions (2)
- 11/13/17 11/13/17 -
- 11/26/17 11/26/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 26, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Contact #2 Year 2 GSK study Prostatic neoplasms NCT00883909
Contact #2 Year 2 GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM
Description
Subject contact
Alias
- UMLS CUI-1
- C0332158
- UMLS CUI-2
- C0681850
Description
If YES, record the date and type of contact.
Data type
text
Alias
- UMLS CUI [1,1]
- C0597535
- UMLS CUI [1,2]
- C1516084
- UMLS CUI [1,3]
- C1705415
Description
Date of contact
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1705415
Description
Type of contact
Data type
text
Description
If YES, ensure that all questions in the CONTACT #2 section have been completed. If NO, check primary reason interview was not completed and do not complete the questions in the CONTACT #2 section.
Data type
text
Alias
- UMLS CUI [1,1]
- C0021822
- UMLS CUI [1,2]
- C0805732
Description
If subject died, record details on the SERIOUS ADVERSE EVENT pages.
Data type
text
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C1548386
Description
Other
Data type
text
Alias
- UMLS CUI [1]
- C0205394
Description
CONTACT #2 - Since Contact #1 (if contact #1 was performed) OR Since the REDUCE 4 Year Contact (if contact #1 was not performed):
Alias
- UMLS CUI-1
- C3812666
- UMLS CUI-2
- C0449788
Description
If YES, Record the date of collection and local PSA results on the PSA RESULTS page.
Data type
text
Alias
- UMLS CUI [1]
- C0201544
Description
If YES, • Enter the biopsy information and the local pathology results on the LOCAL PATHOLOGY RESULTS page. • Send biopsy sample to Central Pathology for Confirmatory Review only if the result is positive for prostate cancer. • If biopsy is positive for PCa enter any available new TNM stage information on the TNM STAGING HISTORY page.
Data type
text
Alias
- UMLS CUI [1]
- C0005558
Description
If YES, • Enter surgical treatment for PCa on the PROSTATIC SURGICAL INTERVENTION page; and, • For radical prostatectomy, enter any local pathology information/ result on LOCAL PATHOLOGY RESULTS page. • For radical prostatectomies, send surgical sample to Central Pathology for confirmatory review, regardless of whether the result is positive or negative for prostate cancer. • For all prostate surgeries other than radical prostatectomies, send surgical sample to Central Pathology for confirmatory review only if the result is positive for prostate cancer. • Enter non-surgical treatment for PCa, on the NON-SURGICAL INTERVENTION FOR PROSTATE CANCER page. • Complete any further TNM staging information on the TNM STAGING HISTORY page.
Data type
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0600139
Description
If YES, • Enter the prostate surgery information on the PROSTATE SURGICAL INTERVENTION page; and, • Enter local pathology results for the surgery on the LOCAL PATHOLOGY RESULTS page. • Send surgical sample to Central Pathology for confirmatory review only if the result is positive for prostate cancer. • Complete any further TNM staging information on the TNM Staging History page.
Data type
text
Alias
- UMLS CUI [1]
- C0194790
Description
comorbidity; hospitalization
Data type
text
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0019993
Description
If YES, Complete the SERIOUS ADVERSE EVENT pages and ensure they are faxed to GSK within 24 hours of becoming aware of the event.
Data type
text
Alias
- UMLS CUI [1]
- C1519255
Description
Chronic concomitant medications include all prescription and nonprescription medication including vitamins, supplements and herbal remedies. Specifically include the use of dutasteride [Avodart ®] or finasteride [Proscar ® and Propecia ®]. If YES, • Enter information for all changes in chronic medications on the CONCOMITANT MEDICATIONS page(s).
Data type
text
Alias
- UMLS CUI [1]
- C0580105
Similar models
Contact #2 Year 2 GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM
C0750480 (UMLS CUI [1,2])
C1516084 (UMLS CUI [1,2])
C1705415 (UMLS CUI [1,3])
C1705415 (UMLS CUI [1,2])
C0805732 (UMLS CUI [1,2])
C1548386 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0449788 (UMLS CUI-2)
C0600139 (UMLS CUI [1,2])
C0019993 (UMLS CUI [1,2])